LXEO
Lexeo Therapeutics
$4.47
−$0.19 (−4.08%)Jul 27, 2026
Key metrics
The numbers that frame LXEO today
- Market cap
- $350.99M
- P/E (TTM)
- -4.0
- EV / FCF
- -2.9
- ROIC
- -61.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.60
- 52wk High
- $10.99
Growth
Revenue and earnings trend for LXEO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LXEO
Is Lexeo Therapeutics a good buy?
No. Lexeo Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Lexeo Therapeutics is selling at a very high price.
What is the market capitalization of LXEO?
Lexeo Therapeutics's market capitalization is $350.99M.
What is the P/E ratio for LXEO stock?
Lexeo Therapeutics's current P/E ratio is -4.
What is the 52-week high for LXEO stock?
The 52-week high for Lexeo Therapeutics is $10.99. The current close of $4.47 is 59.3% below that high.
What is the 52-week low for LXEO stock?
The 52-week low for Lexeo Therapeutics is $3.60. The current close of $4.47 is 24.2% above that low.
Does LXEO stock pay dividends?
Lexeo Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LXEO?
Lexeo Therapeutics's Debt / Equity ratio is 0.03.